Schedule an Appointment Pay Bill View My Results

Test Directory

Test Directory Neuron Specific Enolase (NSE)

Neuron Specific Enolase (NSE)

Test Summary

Quantitative determination of NSE in serum may be valuable in the management of patients with suspected or diagnosed SCLC or neuroblastoma, to monitor the effect of treatment, to aid in the detection of recurrent disease, and to evaluate prognosis in patients.

Aliases

Specimen Collection

Special Instructions

N/A

Preferred Specimen

1 mL serum

Minimum Volume

0.3 mL

Instructions

N/A

Patient Preparation

N/A

Storage

Plastic screw-cap vial

Transport Temperature

Room temperature

Specimen Stability

Room temperature: 7 days
Refrigerated: 7 days
Frozen: 30 days

Limitations

N/A

Other Acceptable Specimens

N/A

Unacceptable Specimens

Hemolysis

Order Code

NSE

EPIC (Premier) Code

LAB2220

Includes

N/A

CPT Code

86316

Billing Code

670360

CPT Statement

Methodology

Immunofluorescence Assay (IFA)

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675

Department

Reference Testing

Reference Range

≤14 ng/mL

Setup Schedule / Expected Turnaround Time

Wednesday, Saturday; Report available: 2 - 4 days